Skip to main content

Month: March 2023

Parsons Awarded $16 Million US Army Intelligence Contract

CENTREVILLE, Va., March 27, 2023 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that the company was awarded a $16 million firm-fixed-price contract by the U.S. Army for collection, processing, and dissemination of high-fidelity signature data. This contract has a five-year period of performance and is new work for the firm. “Parsons has delivered actionable solutions to the Department of Defense and federal agencies for more than 40 years,” said James Lackey, senior vice president for Parsons’ Mission Solutions sector. “As connectivity evolves, geopolitical conditions shift, and near-peer threats loom, our innovation and agility are bolstering readiness to help our nation confront rapidly evolving security challenges in the all-domain battlespace.” Parsons provides tailored intelligence solutions that accelerate...

Continue reading

Todos Medical Begins Trading on the OTC Pink Marketplace

New York, NY, Alpharetta, GA, Tel Aviv, ISRAEL, March 27, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its Ordinary shares will begin trading on the OTC Pink marketplace beginning on March 27, 2023 as a result of the Company’s closing bid price falling below $0.001 for 5 consecutive trading days, from March 20, 2023 through March 24, 2023. For more information, please visit todosmedical.com. For more information on the Company’s 3CL protease inhibitor dietary supplement that provides immune support with 3CL protease inhibition. please visit www.mytollovid.com. About Todos Medical Ltd. Founded in Rehovot, Israel with offices in New York City, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic...

Continue reading

Broadwind Names Jeanette Press to Board of Directors

CICERO, Ill., March 27, 2023 (GLOBE NEWSWIRE) — Broadwind, Inc. (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced the appointment of Ms. Jeanette A. Press to its Board of Directors (the “Board”), effective March 22, 2023. With the appointment of Ms. Press, the Board returned its size to seven members, six of whom are independent. Ms. Press will serve as a member of the Board effective immediately, and the Board has determined to nominate Ms. Press for re-election as a director at the 2023 annual meeting of stockholders (the “2023 Annual Meeting”). She will also serve as a member of both the Audit and the Governance/Nominating committees of the Board. “Jeanette is a results-driven executive with proven expertise leading business...

Continue reading

Form 8.3 – [EMIS Group plc – 24 03 2023] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree EMIS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

MAG Silver Reports 2022 Annual Results

VANCOUVER, British Columbia, March 27, 2023 (GLOBE NEWSWIRE) — MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG”, or the “Company”) announces the Company’s audited consolidated financial results for the year ended December 31, 2022. For details of the audited consolidated financial statements, Management’s Discussion and Analysis, Annual Information Form and Annual Report on Form 40-F for the year ended December 31, 2022, please see the Company’s filings on SEDAR (www.sedar.com) or on EDGAR (www.sec.gov). All amounts herein are reported in $000s of United States dollars (“US$”) unless otherwise specified. KEY HIGHLIGHTS (on a 100% basis unless otherwise noted)The Juanicipio Project was connected to the national power grid on December 28, 2022. With the entire system energized, commissioning of the plant commenced in early...

Continue reading

Alamos Gold Files Technical Report for the Mulatos Property

TORONTO, March 27, 2023 (GLOBE NEWSWIRE) — Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today announced that it has filed a technical report for its Mulatos Property, located in Sonora, Mexico. The report was prepared in accordance with National Instrument 43-101 – Standards for Disclosure for Mineral Projects and is available under the Company’s profile on SEDAR at www.sedar.com and on the Alamos website at www.alamosgold.com. About Alamos Alamos is a Canadian-based intermediate gold producer with diversified production from three operating mines in North America. This includes the Young-Davidson and Island Gold mines in northern Ontario, Canada and the Mulatos mine in Sonora State, Mexico. Additionally, the Company has a strong portfolio of growth projects, including the Phase 3+ Expansion at Island Gold,...

Continue reading

Warrants of series TO5 B were subscribed to approximately 70.2 percent and Terranet receives approximately SEK 3.8 million

Terranet AB (“Terranet” or the “Company”) today announces the outcome of the exercise of warrants of series TO5 B. In total, 8,655,357 warrants of series TO5 B were exercised, corresponding to approximately 70.2 percent of the total number of outstanding warrants of series TO5 B, for subscription of 8,655,357 B-shares at a subscription price of SEK 0.44 per share. Terranet will receive approximately SEK 3.8 million before issuing costs through the exercise of the warrants of series TO5 B. BackgroundThe exercise period for exercise of the warrants of series TO5 B took place from March 13, 2023, up to and including March 24, 2023. The subscription price per B-share for exercising the warrants of series TO5 B was set to SEK 0.44. In total, 8,655,357 warrants of series TO5 B were exercised for subscription of 8,655,357...

Continue reading

Fairmount Tire & Rubber Increases Distribution Efficiency and Delivery Capacity with Descartes’ Last Mile Delivery Solution

ATLANTA and LONDON, March 27, 2023 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that wholesale tire distributor Fairmount Tire & Rubber is using Descartes’ last mile delivery solution to digitize B2B ecommerce delivery operations across its five warehouse locations serving customers in California, Arizona, Nevada and Utah. The cloud-based solution helped the company to complete more stops per route, add between two-to-three additional delivery runs per day and enhance the customer experience by providing customers with real-time, map-based tracking. “At Fairmount Tire, we’re obsessed with creating a frictionless, expedient customer experience,” said Scott Dushane, Director of IT at Fairmount Tire. “In our highly competitive...

Continue reading

BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

Expanded and advanced oncology pipeline to 20 programs in 24 ongoing clinical trials including five ongoing randomized Phase 2 clinical trials; multiple trials with registrational potential expected to be initiated in 2023 and 2024 Announced licensing agreement with OncoC4 to complement the Company’s oncology portfolio with clinical stage next-generation immune checkpoint modulator; a randomized Phase 3 trial planned to start in 2023 Initiated Phase 1 trials for four mRNA vaccine candidates in the infectious disease field Approximately 2 billion doses of COMIRNATY® invoiced in 2022, including approximately 550 million doses of Omicron-adapted bivalent COVID-19 vaccines Fourth quarter and full year revenues of €4.3 billion1 and €17.3 billion1, respectively Full year net profit of €9.4 billion and fully diluted earnings per share of €37.77...

Continue reading

Wearable Devices to Showcase Embedded Machine Learning AI Technology at tinyML Summit 2023

The Company will demonstrate how its AI-based neural input technology interprets neural signals to control digital devices using touchless finger movements YOKNEAM ILLIT, ISRAEL, March 27, 2023 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a growth company developing a wrist-worn neural interface technology for B2B and B2C customers, today announced that it will exhibit its AI-based neural input technology at tinyML Summit 2023 (the “Summit”). The Summit is held at the Hyatt Regency San Francisco Airport in Burlingame, California, from Monday, March 27, 2023 through Wednesday, March 29, 2023. At the Summit, the Company will showcase its advanced artificial intelligence and miniaturized electronics and the technology’s ability to capture, decipher and utilize unique biopotential...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.